Adenoidectomy, Tonsillectomy in Childhood Tied to Risk for Adult Chronic Rhinosinusitis

Why It Matters

The findings prompt clinicians to weigh long‑term sinus health when recommending adenotonsillectomy for recurrent infections, potentially reshaping pediatric ENT decision‑making.

Key Takeaways

• Adenoidectomy alone raises adult CRSsNP risk (HR 1.55).
• Tonsillectomy + adenoidectomy for infections increase CRSwNP (HR 1.63).
• Combined infection surgery doubles adult sinus surgery odds (HR 1.97).
• Obstructive sleep apnea surgeries show no CRS risk increase.
• Infection predisposition, not surgery, may drive adult CRS.

Pulse Analysis

Pediatric adenotonsillectomy remains one of the most common ENT procedures in the United States, traditionally justified by recurrent infections, obstructive sleep apnea, or airway obstruction. While the immediate benefits—reduced throat infections and improved breathing—are well documented, long‑term sequelae have received limited attention. Recent access to large‑scale electronic health‑record databases, such as TriNetX, now enables researchers to trace outcomes decades after the initial surgery, offering a broader perspective on how early interventions may echo into adulthood.

The study published in The Laryngoscope examined adults over 18 who had or had not undergone adenotonsillectomy as children. Hazard ratios revealed a nuanced picture: adenoidectomy alone was associated with a 55% higher risk of chronic rhinosinusitis without polyps, while combined tonsillectomy‑adenoidectomy for infectious reasons more than doubled the odds of requiring sinus surgery later in life. Notably, procedures performed for obstructive sleep apnea did not increase CRS risk, underscoring that the underlying indication—not the removal of lymphoid tissue—drives the observed association. These results align with emerging theories that chronic bacterial colonization or immune dysregulation in early childhood may predispose patients to persistent sinus inflammation.

For clinicians, the implications are twofold. First, a more conservative approach to adenotonsillectomy may be warranted when infections are intermittent or manageable with medical therapy, balancing short‑term relief against potential lifelong sinus disease. Second, patients with a history of childhood adenoidectomy or tonsillectomy for infections should be monitored for early signs of CRS, allowing timely intervention with medical or biologic therapies. Future research should explore whether targeted antimicrobial strategies or immunomodulation in childhood could mitigate the heightened CRS risk identified in this cohort.